Searched for
BIOPHARMACEUTICAL GROWTH 2026
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Biocon reports 63% YoY fall in Q4 profit, final dividend of Rs. 0.50 recommendedBiocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to exceptional charges im...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- US stock market today: why Dow Jones crashing big while S&P 500 and Nasdaq are rising? Dow down by 200 points as oil surge, Fed jitters, and Big Tech earnings split market directionUS stock market today: Why Dow Jones Industrial Average falls while S&P 500 and Nasdaq Composite hold steady? US stock market today shows a...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIf you are putting fresh money into the stock market (or even looking to rejig your existing portfolio), it would be best not to react to w...
- These large- and mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 26%, according to analystsGlobal equity markets will continue hitting sudden air pockets and face turbulence. They are probably still not discounting the impact of a...
- US Stocks: IPO proceeds to quadruple to record $160 bn in 2026 as dealmaking rebounds: GoldmanU.S. equity markets are set for a sharp rebound in IPOs in 2026, Goldman Sachs analysts said, forecasting proceeds quadrupling to a record ...
- Budget 2026 | Strategic sectors get the attention; markets in range: Sanjeev PrasadThe Indian budget offers a modest economic boost with increased capital expenditure, focusing on strategic sectors. While positive for earn...
- PHARMEXCIL discusses export momentum, MSME support with govtPHARMEXCIL leadership met with senior Indian government officials to strategize for global market expansion and policy alignment in the pha...
- Biocon to make Biocon Biologics a wholly owned subsidiaryBiocon is set to fully integrate its biosimilar arm, Biocon Biologics. This move will make Biocon Biologics a wholly owned subsidiary. Bioc...
- Biocon sees GLP-1 weight-loss therapy as a future growth driverBiocon will strengthen its insulin business while advancing in GLP-1 therapies, with semaglutide in Phase-III trials and a planned 2027 Ind...
- Chennai’s office stock set to exceed 100 million sq ft by 2026 endChennai's office stock is set to surpass 100 million sq ft by 2026, driven by increased private equity investments. The city’s office marke...
- BITS Pilani receives Rs 60 cr from Centre for advanced research facilitiesBITS Pilani has won the Sathi project and received a grant of Rs 60 crore. It will establish advanced research facilities and a sophisticat...
- Budget 2024: A shot in the arm for green energy initiativesIn the Interim Budget, Finance Minister Nirmala Sitharaman introduced financial assistance for the procurement of biomass aggregation machi...
- Advent closes in on Suven Pharma buyoutPromoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...
- Samsung to invest $356 billion over five years in strategic sectorsSouth Korea's top conglomerate said on Tuesday the investments through 2026 are expected to help Samsung drive long-term growth in strategi...
- Biocon Q2 net moves up 20% to Rs 89.22 croreBiocon reported 20.26% increase in net profit for the quarter ended September 30 to Rs 89.22 crore on the back of strong sales.
Load More
